At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ADC Agree
Pre-Mkt 06-01 06:27:47 EDT
74.15
-0.13
-0.18%
High74.37Low73.46Vol1.80M
Open74.11D1 Closing74.28Amplitude1.23%
Mkt Cap8.90BTradable Cap8.04BTotal Shares120.03M
T/O133.15MT/O Rate1.66%Tradable Shares108.37M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Jefferies Sticks to Its Buy Rating for Agree Realty (ADC)
TIPRANKS  ·  33 minutes ago
Jefferies Sticks to Its Buy Rating for Agree Realty (ADC)
Agree Realty Corp : Jefferies Assumes Coverage With Buy Rating; Price Target $84 VS $92
THOMSON REUTERS  ·  15:58
Agree Realty Corp : Jefferies Assumes Coverage With Buy Rating; Price Target $84 VS $92
U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake
Reuters  ·  15:39
U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake
Revised Title
Stock News  ·  06:56
Revised Title
China Biopharma's Claudin 18.2 ADC LM-302 Demonstrates Encouraging Phase II Data in First-Line Gastric Cancer at ASCO 2026
Stock News  ·  06:50
China Biopharma's Claudin 18.2 ADC LM-302 Demonstrates Encouraging Phase II Data in First-Line Gastric Cancer at ASCO 2026
Sino Biopharm Showcases Promising Phase I Data for Novel EGFR/c-Met ADC at ASCO 2026
TIPRANKS  ·  06:37
Sino Biopharm Showcases Promising Phase I Data for Novel EGFR/c-Met ADC at ASCO 2026
Nobody Can Agree How to Keep the Sharks Out of South Africa's New Club Med -- WSJ
Dow Jones  ·  05-31 11:00
Nobody Can Agree How to Keep the Sharks Out of South Africa's New Club Med -- WSJ
ANTENGENE-B Shares Surge Over 5% Following Clinical Approval for Key Phase III Study of ADC Therapy ATG-022 in Gastric Adenocarcinoma
Stock News  ·  05-29
ANTENGENE-B Shares Surge Over 5% Following Clinical Approval for Key Phase III Study of ADC Therapy ATG-022 in Gastric Adenocarcinoma
Essential Performance and Real-time Control Without the Baggage
GlobeNewswire  ·  05-29
Essential Performance and Real-time Control Without the Baggage
Henlius Starts Global Phase 2/3 Trial of ADC HLX43 in Advanced Lung Cancer
TIPRANKS  ·  05-28
Henlius Starts Global Phase 2/3 Trial of ADC HLX43 in Advanced Lung Cancer
AbbVie's CD123 ADC Receives FDA Approval for Market Launch
Stock News  ·  05-28
AbbVie's CD123 ADC Receives FDA Approval for Market Launch
“Foundational to Installation Infrastructure”: Comcast Stock (NASDAQ:CMCSA) Gains Discussing Future of Community Connections
TIPRANKS  ·  05-28
“Foundational to Installation Infrastructure”: Comcast Stock (NASDAQ:CMCSA) Gains Discussing Future of Community Connections
Asahi Kaisei acquires license rights for ADC tech from Noguchi Institute
TIPRANKS  ·  05-27
Asahi Kaisei acquires license rights for ADC tech from Noguchi Institute
DUALITYBIO-B Surges Over 5% on Global Phase III Trial Milestone for B7-H3 ADC with BioNTech
Stock News  ·  05-27
DUALITYBIO-B Surges Over 5% on Global Phase III Trial Milestone for B7-H3 ADC with BioNTech
U.S., India Agree to Deepen Critical Minerals, Rare Earths Partnership
Dow Jones  ·  05-26
U.S., India Agree to Deepen Critical Minerals, Rare Earths Partnership
These German Politicians Agree With Trump: It's Time for U.S. Troops to Get Out -- WSJ
Dow Jones  ·  05-25
These German Politicians Agree With Trump: It's Time for U.S. Troops to Get Out -- WSJ
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
GlobeNewswire  ·  05-22
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
Pete Buttigieg And Donald Trump Agree On Something: Rail Safety Reform
Benzinga  ·  05-22
Pete Buttigieg And Donald Trump Agree On Something: Rail Safety Reform
Kelun-Biotech’s Lung Cancer ADC Regimen Shows Strong Phase III Results at ASCO 2026
TIPRANKS  ·  05-22
Kelun-Biotech’s Lung Cancer ADC Regimen Shows Strong Phase III Results at ASCO 2026
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
GlobeNewswire  ·  05-21
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

Introduction

Company Name.
Agree
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Agree Realty Corporation (the “Company”), a Maryland corporation, is a fully integrated real estate investment trust (“REIT”) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (“GLA”) of approximately 44.9 million square feet.
Issue price:
--